The Three-Layer Energy Stack
Forget stimulants. This stack fixes energy at the source — your mitochondria. Three compounds, three mechanisms, one system rebuilt from the inside out.
Build your own printable peptide tracker
A personalized injection log, weekly dosing schedule and dated calendar — your compounds filled in, ready to print. Free to build and preview; $5/month to unlock printing.
Why Stimulants Fail
Caffeine, ephedrine, energy drinks — they don't create energy. They borrow it. They squeeze more out of a system that's already running on fumes, then leave you worse off when the spike fades. The real issue isn't stimulation. It's production.
Stimulant Model
Forces existing energy systems to work harder. Short-term spike → crash → dependency. Doesn't address why energy is low in the first place.
Mitochondrial Model
Fix the power plants themselves. More mitochondria, better efficiency, less degradation. Baseline improvement that compounds over time.
NAD+ Decline With Age
Your cellular fuel co-factor drops by half before you hit 40.
Based on tissue NAD+ measurements. Imai & Guarente (2014), Trends in Cell Biology.
Three Layers, One System
Each compound targets a different layer of mitochondrial energy production. Together, they build, fuel, and protect your cellular power grid.
NAD+ (NMN / NR)
The fuel co-factor. Helps existing mitochondria produce ATP more efficiently while supporting DNA repair via PARP and sirtuin pathways. Better output, better repair, cleaner signaling.
MOTS-c
The biogenesis signal. A mitochondrial-derived peptide that tells your cells to build more mitochondria and improve metabolic flexibility. Not just tuning the engine — adding cylinders.
5-Amino-1MQ
The NAD+ preserver. Inhibits NNMT — the enzyme that degrades NAD+. Makes the entire stack stick long-term instead of being a temporary boost. Plus: fat loss co-benefit via adipose tissue pathways.
NAD+ — Fuel Support
NAD+ is the critical coenzyme in every cell that converts nutrients into ATP — your body's energy currency. It also activates sirtuins (longevity proteins) and fuels DNA repair through PARPs. The problem: your NAD+ levels plummet with age.
🔋 ATP Production
NAD+ shuttles electrons in the mitochondrial electron transport chain. More NAD+ = more efficient ATP generation from every meal.
🧬 DNA Repair
PARPs consume NAD+ to fix DNA damage. Without enough NAD+, repair slows and damage accumulates — accelerating aging.
🔄 Sirtuin Activation
Sirtuins (SIRT1–7) are NAD+-dependent enzymes that regulate metabolism, inflammation, and cellular stress response.
📡 Cellular Signaling
NAD+ is consumed in signaling reactions (CD38, SARM1). Maintaining levels keeps communication pathways clean and responsive.
NAD+ Precursor Comparison
Three main ways to raise NAD+ — each with different trade-offs.
| Precursor | Route | Bioavailability | Speed | Cost | Evidence |
|---|---|---|---|---|---|
| NMN (sublingual) | Oral / sublingual | Good — direct NAD+ precursor | Hours | $$ | Strong preclinical, growing clinical |
| NR (Niagen) | Oral | Good — proven blood NAD+ increase | Hours | $$ | Multiple human RCTs |
| IV NAD+ | Intravenous | Direct — bypasses digestion | Minutes | $$$$ | Clinical use, limited formal trials |
Research: Imai & Guarente (2014) established the NAD+/sirtuin axis as central to aging. Yoshino et al. (2018) showed NMN restores NAD+ levels and improves metabolic function in aging mice, with human trials confirming NMN raises blood NAD+ safely at doses up to 1200mg/day.
MOTS-c — System Upgrade Signal
MOTS-c is a 16-amino-acid peptide encoded in mitochondrial DNA — making it one of the first known mitochondrial-derived signaling molecules. It tells your cells to adapt: build more mitochondria, switch fuels more efficiently, and activate metabolic stress response pathways.
🏗️ Mitochondrial Biogenesis
Activates PGC-1α and related pathways that trigger the production of entirely new mitochondria. More power plants, not just better fuel.
⚙️ AMPK Activation
MOTS-c activates AMPK — the master metabolic sensor. This triggers fat oxidation, glucose uptake, and cellular stress resilience pathways.
🔄 Metabolic Flexibility
Improves the cell's ability to switch between fat and glucose as fuel sources. Better metabolic flexibility = more consistent energy output.
🏃 Exercise Mimetic
MOTS-c levels rise during exercise. Supplementation may activate some of the same pathways exercise triggers — mitochondrial biogenesis and metabolic adaptation.
MOTS-c Research Highlights
Lee et al. (2015) — Cell Metabolism
First identification of MOTS-c as a mitochondrial-encoded signaling peptide. Showed MOTS-c regulates metabolic homeostasis and prevents age-dependent and diet-induced insulin resistance in mice.
Reynolds et al. (2021) — Nature Communications
Demonstrated that MOTS-c is exercise-induced, and that treatment with MOTS-c improved physical performance in aged mice — suggesting it as a regulator of age-dependent physical decline.
5-Amino-1MQ — NAD+ Preserver
5-Amino-1MQ is a small-molecule NNMT inhibitor. NNMT (nicotinamide N-methyltransferase) is an enzyme that breaks down NAD+ precursors — essentially draining your NAD+ pool. Block it, and NAD+ levels stay elevated longer. This is what makes the stack sustainable.
🔒 NNMT Inhibition
NNMT methylates nicotinamide, diverting it away from NAD+ production. 5-Amino-1MQ selectively blocks this enzyme, keeping more nicotinamide available for NAD+ synthesis.
⏱️ Sustained NAD+ Levels
Without NNMT inhibition, NAD+ supplementation is a leaky bucket. 5-Amino-1MQ plugs the drain — making NMN/NR supplementation more effective over time.
🔥 Fat Loss Co-Benefit
NNMT is highly expressed in adipose tissue. Inhibition reduces fat cell size and lipogenesis. Neelakantan et al. showed significant fat mass reduction in diet-induced obesity models.
💊 Oral Bioavailability
Unlike many peptides requiring injection, 5-Amino-1MQ is a small molecule with good oral bioavailability. University of Texas research confirmed effective oral dosing.
Key Research
Neelakantan et al. (2018) — Biochemical Journal
Developed selective, membrane-permeable NNMT inhibitors including 5-Amino-1MQ. Showed reduction in fat mass and adipocyte size in diet-induced obesity mouse models without affecting food intake.
Kannt et al. (2015) — J Clin Endocrinol Metab
Established the link between NNMT expression in adipose tissue and insulin resistance, providing the rationale for NNMT inhibition as a metabolic intervention target.
Why Together > Individual
Each compound alone addresses one piece of the puzzle. Together, they create a reinforcing loop: fuel the mitochondria you have, build new ones, and protect the fuel supply from degradation.
NAD+
Fuels ATP production
MOTS-c
Builds more mitochondria
5-Amino-1MQ
Preserves NAD+ levels
Reinforcing Loop
NAD+ fuels more efficient mitochondria. MOTS-c creates more of them. 5-Amino-1MQ keeps NAD+ from being broken down. Each compound amplifies the others.
Compound Over Time
Stimulants work day one and plateau. This stack takes weeks to build momentum — but the gains compound as new mitochondria come online and NAD+ levels stabilize.
Different Targets
No redundancy. Layer 1 is substrate supply. Layer 2 is structural expansion. Layer 3 is degradation prevention. Three distinct mechanisms, one integrated outcome.
Dosing Protocol
Research-referenced dosing ranges. These are informational — not prescriptive. Always consult a healthcare provider before starting any protocol.
| Compound | Dose | Frequency | Timing | Route |
|---|---|---|---|---|
| NMN | 500–1,000 mg/day | Daily | Morning | Oral |
| MOTS-c | 5–10 mg | 5 days on / 2 off | Morning | SubQ |
| 5-Amino-1MQ | 50–100 mg/day | Daily | Morning | Oral |
⚠️ Protocol Notes
- Start with lower doses and titrate up over 2–4 weeks
- MOTS-c requires subcutaneous injection — reconstitute with bacteriostatic water
- Morning dosing aligns with circadian NAD+ cycling
- Consider cycling the full stack: 8 weeks on, 2 weeks off
- CoQ10 and B-vitamins are useful cofactors to add alongside
Who This Stack Is For
This isn't for everyone. It's for people whose energy problems don't respond to sleep, diet, and exercise alone — and who want to address the root cause rather than masking symptoms.
Chronic Fatigue
Persistent low energy despite adequate sleep and nutrition
Age-Related Decline
NAD+ drops 50%+ by age 40 — mitochondrial support becomes critical
Brain Fog
Cognitive performance depends on neuronal mitochondrial health
Athletes
Enhanced mitochondrial density and metabolic flexibility for performance
Recovery
Faster cellular repair and reduced inflammation via NAD+/sirtuin pathways
Monitoring Your Progress
Subjective energy improvements can be placebo. Track these biomarkers and metrics to know if the stack is actually working.
-
NAD+ Blood Test
Intracellular NAD+ testing (e.g., Jinfiniti) measures your actual NAD+ levels. Test before starting and at 4–8 week intervals to verify supplementation is working.
-
Subjective Energy Tracking
Daily 1–10 energy rating at consistent times (morning, afternoon, evening). Look for baseline shift over 4+ weeks, not day-to-day variation.
-
Body Composition
5-Amino-1MQ's fat loss benefit is measurable. Track body fat percentage and lean mass with a DEXA scan or smart scale at monthly intervals.
-
Cognitive Performance
Use consistent cognitive tasks (reaction time tests, focus duration tracking) to measure brain fog improvements objectively.
-
Sleep Quality
Wearable data (HRV, deep sleep duration, recovery scores) can indicate improved mitochondrial function and cellular repair during sleep.
Stack Supplements & Tools
Cofactors and tools that support the mitochondrial energy stack.
Affiliate links — support HighPeptides at no extra cost.
Research Peptides & Compounds
Looking for research-grade MOTS-c, 5-Amino-1MQ, and other compounds? Swiss Chems offers third-party tested products.
Browse Swiss Chems →Related Resources
Key Takeaways
✅ What We Know
- NAD+ declines significantly with age — supplementation raises blood levels
- MOTS-c is a legitimate mitochondrial signaling peptide with published mechanisms
- 5-Amino-1MQ selectively inhibits NNMT and reduces fat mass in animal models
- Each compound targets a distinct, non-overlapping mechanism of mitochondrial function
- NMN and NR have multiple human safety trials supporting their tolerability
⚠️ What We Don't
- No human RCTs have tested this specific three-compound stack together
- MOTS-c human clinical trial data is still very limited
- 5-Amino-1MQ has no published human trials — evidence is preclinical
- Long-term safety profiles for combination use are unknown
- Optimal dosing ratios for synergistic effects haven't been established
Want the Complete Protocol Guide?
Dosing schedules, interaction warnings, and cycle protocols for 50+ compounds — all in one place.
Get the Guide →Educational content only. Not medical advice. This page is for informational purposes. The mitochondrial energy stack described here combines dietary supplements (NMN), research peptides (MOTS-c), and investigational compounds (5-Amino-1MQ). None of these combinations have been FDA-approved for any condition. 5-Amino-1MQ and MOTS-c are sold for research purposes only. The research cited includes preclinical and early-stage studies — do not interpret as established treatment guidelines. Always consult with a qualified healthcare provider before starting any supplementation or peptide protocol.
Get the Free 2026 Peptide Protocol Stack
Twelve compounds across four pillars — metabolic, tissue repair, longevity, cognitive. Citations included, formatted to print. Sent straight to your inbox.